237 related articles for article (PubMed ID: 31216321)
1. The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial.
Minnaar CA; Kotzen JA; Ayeni OA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
PLoS One; 2019; 14(6):e0217894. PubMed ID: 31216321
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the effects of mEHT on the treatment-related toxicity and quality of life of HIV-positive cervical cancer patients.
Minnaar CA; Kotzen JA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
Int J Hyperthermia; 2020; 37(1):263-272. PubMed ID: 32180481
[No Abstract] [Full Text] [Related]
3. Defining Characteristics of Nodal Disease on PET/CT Scans in Patients With HIV-Positive and -Negative Locally Advanced Cervical Cancer in South Africa.
Minnaar CA; Baeyens A; Ayeni OA; Kotzen JA; Vangu MD
Tomography; 2019 Dec; 5(4):339-345. PubMed ID: 31893232
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of the Abscopal Effect by Modulated Electro-Hyperthermia in Locally Advanced Cervical Cancer Patients.
Minnaar CA; Kotzen JA; Ayeni OA; Vangu MD; Baeyens A
Front Oncol; 2020; 10():376. PubMed ID: 32266151
[No Abstract] [Full Text] [Related]
5. Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients.
Minnaar CA; Maposa I; Kotzen JA; Baeyens A
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158924
[TBL] [Abstract][Full Text] [Related]
6. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
7. HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
Simonds H; Botha MH; Ellmann A; Warwick J; Doruyter A; Neugut AI; Van Der Merwe H; Jacobson JS
Int J Gynecol Cancer; 2019 Oct; 29(8):1252-1257. PubMed ID: 31413068
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth.
Yang W; Han GH; Shin HY; Lee EJ; Cho H; Chay DB; Kim JH
Int J Hyperthermia; 2019; 36(1):9-20. PubMed ID: 30428738
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
[TBL] [Abstract][Full Text] [Related]
10. Roles of posttherapy
Liu FY; Su TP; Wang CC; Chao A; Chou HH; Chang YC; Yen TC; Lai CH
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1197-1204. PubMed ID: 29470614
[TBL] [Abstract][Full Text] [Related]
11. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer.
Harima Y; Ohguri T; Imada H; Sakurai H; Ohno T; Hiraki Y; Tuji K; Tanaka M; Terashima H
Int J Hyperthermia; 2016 Nov; 32(7):801-8. PubMed ID: 27418208
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of ADC
Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
[TBL] [Abstract][Full Text] [Related]
14. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract][Full Text] [Related]
15. (
Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
[TBL] [Abstract][Full Text] [Related]
16. Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients.
Fiorentini G; Sarti D; Casadei V; Milandri C; Dentico P; Mambrini A; Nani R; Fiorentini C; Guadagni S
Integr Cancer Ther; 2019; 18():1534735419878505. PubMed ID: 31561722
[No Abstract] [Full Text] [Related]
17. The effect of modulated electro-hyperthermia on temperature and blood flow in human cervical carcinoma.
Lee SY; Kim JH; Han YH; Cho DH
Int J Hyperthermia; 2018 Nov; 34(7):953-960. PubMed ID: 29297234
[TBL] [Abstract][Full Text] [Related]
18. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.
Su TP; Lin G; Huang YT; Liu FY; Wang CC; Chao A; Chou HH; Yen TC; Lai CH
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):727-734. PubMed ID: 29159572
[TBL] [Abstract][Full Text] [Related]
19. Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
Ioffe YJ; Massad LS; Powell MA; Hagemann AR; Mutch DG; Thaker PH; Schwarz JK; Grigsby PW
Gynecol Obstet Invest; 2018; 83(1):83-89. PubMed ID: 28399524
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
